SALES METANOSULFONATO DE 5-(2-(4-(1,2-BENZOISOTIAZOL-3-IL)- 1-PIPERAZINIL)ETIL)-6-CLORO-1,3-DIHIDRO-2H-INDOL-2-ONA DIHIDRATADAS

La invención se refiere a las sales metanosulfonato de 5-(2-(4-(1,2-benzoisotiazol-3-il)-1-piperazinil)etil)-6-cloro-1,3-dihidro-2H-indol-2-ona dihidratadas, a composiciones farmacéuticas que contienen dichas sales metanosulfonato dihidratadas, y a procedimientos de uso de dichas sales metanosulfona...

Full description

Saved in:
Bibliographic Details
Main Authors BUSCH FRANK ROBERT, CAROL ANNE ROSE, SHINE RUSSELL JAMES
Format Patent
LanguageSpanish
Published 24.07.2000
Edition7
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:La invención se refiere a las sales metanosulfonato de 5-(2-(4-(1,2-benzoisotiazol-3-il)-1-piperazinil)etil)-6-cloro-1,3-dihidro-2H-indol-2-ona dihidratadas, a composiciones farmacéuticas que contienen dichas sales metanosulfonato dihidratadas, y a procedimientos de uso de dichas sales metanosulfonato dihidratadas para tratar trastornos psicóticos. The invention is directed to the mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one, pharmaceutical compositions containing said ziprasidone mesylate dihydrates, and methods of adminsitering the ziprasidone mesylate dihydrates to treat psychotic diseases.
Bibliography:Application Number: CO19970022872